NN Investment Partners Holdings N.V. decreased its position in Ventas, Inc. (NYSE:VTR) by 2.6% during the 2nd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 641,240 shares of the real estate investment trust’s stock after selling 16,809 shares during the period. NN Investment Partners Holdings N.V. owned about 0.18% of Ventas worth $43,829,000 as of its most recent SEC filing.
Other institutional investors have also recently bought and sold shares of the company. BlackRock Inc. raised its holdings in Ventas by 0.4% during the 1st quarter. BlackRock Inc. now owns 36,891,328 shares of the real estate investment trust’s stock valued at $2,354,034,000 after acquiring an additional 158,707 shares during the period. Centersquare Investment Management LLC raised its holdings in Ventas by 397.7% during the 1st quarter. Centersquare Investment Management LLC now owns 19,394,456 shares of the real estate investment trust’s stock valued at $333,092,000 after acquiring an additional 15,497,390 shares during the period. Federated Investors Inc. PA raised its holdings in Ventas by 0.3% during the 1st quarter. Federated Investors Inc. PA now owns 6,320,554 shares of the real estate investment trust’s stock valued at $403,315,000 after acquiring an additional 17,658 shares during the period. Northern Trust Corp raised its holdings in Ventas by 0.3% during the 1st quarter. Northern Trust Corp now owns 6,068,696 shares of the real estate investment trust’s stock valued at $387,243,000 after acquiring an additional 16,774 shares during the period. Finally, Geode Capital Management LLC raised its holdings in Ventas by 8.8% during the 4th quarter. Geode Capital Management LLC now owns 5,762,889 shares of the real estate investment trust’s stock valued at $337,172,000 after acquiring an additional 467,757 shares during the period. Institutional investors and hedge funds own 87.08% of the company’s stock.
Shares of Ventas stock traded up $0.75 during trading on Tuesday, hitting $68.04. The stock had a trading volume of 110,859 shares, compared to its average volume of 1,986,485. The stock has a market capitalization of $24.12 billion, a price-to-earnings ratio of 16.69, a price-to-earnings-growth ratio of 4.37 and a beta of 0.28. The company has a debt-to-equity ratio of 1.05, a quick ratio of 0.56 and a current ratio of 0.56. Ventas, Inc. has a 12 month low of $51.80 and a 12 month high of $73.74. The company’s 50-day moving average price is $67.92.
The firm also recently declared a quarterly dividend, which was paid on Friday, July 12th. Shareholders of record on Monday, July 1st were given a dividend of $0.7925 per share. The ex-dividend date of this dividend was Friday, June 28th. This represents a $3.17 annualized dividend and a yield of 4.66%. Ventas’s payout ratio is 77.89%.
In other Ventas news, Chairman Debra A. Cafaro sold 68,084 shares of the company’s stock in a transaction dated Friday, June 14th. The shares were sold at an average price of $66.54, for a total transaction of $4,530,309.36. Following the completion of the sale, the chairman now directly owns 805,835 shares in the company, valued at $53,620,260.90. The transaction was disclosed in a document filed with the SEC, which is accessible through this link. Also, EVP T Richard Riney sold 29,702 shares of the company’s stock in a transaction dated Thursday, June 20th. The shares were sold at an average price of $70.45, for a total transaction of $2,092,505.90. Following the sale, the executive vice president now owns 163,488 shares of the company’s stock, valued at $11,517,729.60. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 165,866 shares of company stock valued at $11,323,058. Company insiders own 1.40% of the company’s stock.
A number of equities research analysts have issued reports on VTR shares. ValuEngine raised shares of Zynerba Pharmaceuticals from a “hold” rating to a “buy” rating in a report on Friday, May 17th. Mitsubishi UFJ Financial Group boosted their target price on shares of Ventas to $67.00 and gave the company a “neutral” rating in a report on Wednesday, June 19th. Raymond James set a C$13.50 target price on shares of Secure Energy Services and gave the company a “strong-buy” rating in a report on Tuesday, April 30th. Royal Bank of Canada decreased their price target on shares of from GBX 80 ($1.05) to GBX 75 ($0.98) and set an “outperform” rating on the stock in a report on Thursday, June 20th. Finally, Morgan Stanley set a $111.00 price target on shares of Procter & Gamble and gave the stock a “buy” rating in a report on Thursday, March 28th. Two research analysts have rated the stock with a sell rating, eleven have assigned a hold rating and three have given a buy rating to the company. Ventas presently has an average rating of “Hold” and a consensus target price of $65.12.
Ventas, Inc, an S&P 500 company, is a leading real estate investment trust. Its diverse portfolio of approximately 1,200 assets in the United States, Canada and the United Kingdom consists of seniors housing communities, medical office buildings, university-based research and innovation centers, inpatient rehabilitation and long-term acute care facilities, and health systems.
Read More: Trade War
Want to see what other hedge funds are holding VTR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Ventas, Inc. (NYSE:VTR).
Receive News & Ratings for Ventas Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ventas and related companies with MarketBeat.com's FREE daily email newsletter.